B 1-6 Coxsackievirus A 1-24 CF Antisera Suppliers
www.cdc.gov | Send Inquiry | Phone: +1-(888)-232-6348
FDA Registration: 1050190 Employee Count: ~180
Products: Healthcare Service, Arizona Spp Antiserum (FDA Code: GTE), Fluorescent B. Pertussis Antisera (FDA Code: GOZ), Brucella Spp Agglutination Antigen (FDA Code: GSO), Escherichia Coli Antisera (FDA Code: GNA), Positive and Negative Febrile Antigen Control Serum (FDA Code: GSN), ...
Centers for Disease Control and Prevention is an online source for health information. more...
www.lonza.com/group/en/company/sites/america/lonza_walkersville.html | Send Inquiry | Phone: +1-(201)-316-9200
FDA Registration: 1114298 Year Established: 1984 Quality: ISO 9001 Certified
Products: Balanced Salt Solutions (FDA Code: KIP), B 1-6 Coxsackievirus A 1-24 CF Antisera (FDA Code: GNO), Influenza Virus (A, B, C) Antisera (FDA Code: GNW), Coxsackievirus A 1-24 CF Antigen (FDA Code: GNG), Influenza Virus CF Antigen (FDA Code: GNX), Mycoplasma Spp Antiserum (FDA Code: GSA), ...
Lonza Walkersville, Inc. is engaged in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. We supply products to the pharmaceutical, healthca more...
Phone: +39-(6)-9195735
Products: C-Reactive Protein Test System (FDA Code: DCN), Rheumatoid Factor Test System (FDA Code: DHR), 2 Herpesvirus Hominis 1 CF Antigen (FDA Code: GQN), 2 Herpesvirus Hominis 1 Cf Antisera (FDA Code: GQO), Adenovirus 1-33 CF Antigen (FDA Code: GOD), Adenovirus 1-33 CF Antisera (FDA Code: GOA), ...
Alfa Biotech Spa specializes in offering vaccines, blood products and diagnostic products for laboratory & medical use. more...
Coxsackievirus serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to coxsackievirus in serum. Additionally, some of these reagents consist of coxsackievirus antisera conjugated with a fluorescent dye that are used to identify coxsackievirus from clinical specimens or from tissue culture isolates derived from clinical specimens. The identification aids in the diagnosis of coxsackievirus infections and provides epidemiological information on diseases caused by these viruses. Coxsackieviruses produce a variety of infections, including common colds, meningitis (inflammation of brain and spinal cord membranes), herpangina (brief fever accompanied by ulcerated lesions of the throat), and myopericarditis (inflammation of heart tissue).
Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to 866.9.
